Skip to main navigation Skip to search Skip to main content

Evaluation of Helicobacter species in inflammatory bowel disease

  • S. J. Bell
  • , S. A. Chisholm
  • , R. J. Owen
  • , S. P. Borriello
  • , M. A. Kamm

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: Bacteria have been implicated in the pathogenesis of inflammatory bowel disease. Helicobacter species have been shown to cause colitis in animal models and have been identified in human diarrhoeal illness and Crohn's disease. Aim: To determine whether Helicobacter species are present in human inflammatory bowel disease tissue. Methods: Thirty patients undergoing colonoscopy for clinical reasons were studied. Nine had Crohn's disease, 11 had ulcerative colitis and 10 had histologically normal colons. Tissue was snap-frozen at -70°C. DNA was extracted and examined by five different polymerase chain reaction (PCR) assays that were either genus or species specific for Helicobacter. Results: Analyses of colonic biopsies by two Helicobacter genus-specific PCR assays, two H. pylori-specific assays and a PCR assay designed to amplify fragments of 'H. heilmannii'-like organisms demonstrated that product was not generated by any test. Internal control PCR demonstrated that PCR results for the five assays were not negative due to the presence of residual substances inhibitory to PCR. Conclusions: Helicobacter species were not identified in this study, using multiple PCRs to eliminate the problems of non-specific cross-reaction. This suggests that Helicobacter species do not play a role in the pathogenesis of inflammatory bowel disease.

Original languageEnglish
Pages (from-to)481-486
Number of pages6
JournalAlimentary Pharmacology and Therapeutics
Volume18
Issue number5
DOIs
Publication statusPublished - Sept 2003
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this